These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6201226)

  • 21. Accumulation of natural killer cells after hepatic artery embolisation in the midgut carcinoid syndrome.
    Wängberg B; Ahlman H; Tylén U; Nilsson O; Hermodsson S; Hellstrand K
    Br J Cancer; 1995 Mar; 71(3):617-8. PubMed ID: 7880747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of preoperative embolization of the right portal vein and hepatic artery prior to major hepatectomy in high-risk patients: a preliminary report.
    Inaba S; Takada T; Amano H; Yoshida M; Yamakawa Y; Yasuda H; Takada Y; Takeshita K; Koutake H; Takada K; Furui S; Hijikata H; Takada K
    Hepatogastroenterology; 2000; 47(34):1077-81. PubMed ID: 11020883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparative assessment of the effectiveness of dearterialization of the liver and intraorgan chemotherapy in patients with liver cancer].
    Borisov AE; Zemlianoĭ VP; Nepomniashchaia SL
    Vestn Khir Im I I Grek; 1998; 157(1):28-31. PubMed ID: 9611310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective review of transcatheter hepatic arterial embolisation for ruptured hepatocellular carcinoma.
    Leung CS; Tang CN; Fung KH; Li MK
    J R Coll Surg Edinb; 2002 Oct; 47(5):685-8. PubMed ID: 12463708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
    Diamandidou E; Ajani JA; Yang DJ; Chuang VP; Brown CA; Carrasco HC; Lawrence DD; Wallace S
    AJR Am J Roentgenol; 1998 Feb; 170(2):339-44. PubMed ID: 9456942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic arteriography in patients with hepatocellular carcinoma: change in findings caused by balloon occlusion of tumor-draining hepatic veins.
    Kanazawa S; Yasui K; Doke T; Mitogawa Y; Hiraki Y
    AJR Am J Roentgenol; 1995 Dec; 165(6):1415-9. PubMed ID: 7484576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatic artery embolization for primary hepatic carcinoma].
    Ye WJ
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):151-3. PubMed ID: 2553366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic artery embolization for metastatic endocrine-secreting tumors of the pancreas. Report of two cases.
    Clouse ME; Lee RG; Duszlak EJ; Lokich JJ; Alday MT
    Gastroenterology; 1983 Nov; 85(5):1183-6. PubMed ID: 6194040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
    Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
    Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
    Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.
    Tournoux-Facon C; Paoletti X; Barbare JC; Bouché O; Rougier P; Dahan L; Lombard-Bohas C; Faroux R; Raoul JL; Bedenne L; Bonnetain F
    J Hepatol; 2011 Jan; 54(1):108-14. PubMed ID: 21047696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
    Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proximal versus peripheral hepatic artery embolization experimental study in monkeys.
    Doppman JL; Girton M; Kahn R
    Radiology; 1978 Sep; 128(3):577-88. PubMed ID: 79188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The carcinoid syndrome: palliation by hepatic artery embolization.
    Carrasco CH; Charnsangavej C; Ajani J; Samaan NA; Richli W; Wallace S
    AJR Am J Roentgenol; 1986 Jul; 147(1):149-54. PubMed ID: 2424291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of twelve-hour preprandial and two-hour postprandial serum bile acids concentrations for diagnosis of hepatobiliary disease in dogs.
    Center SA; ManWarren T; Slater MR; Wilentz E
    J Am Vet Med Assoc; 1991 Jul; 199(2):217-26. PubMed ID: 1890031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure.
    Didolkar MS; Fitzpatrick JL; Elias EG; Whitley N; Keramati B; Suter CM; Brown S
    Surg Gynecol Obstet; 1989 Jul; 169(1):17-26. PubMed ID: 2740965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of emergent embolisation of ruptured hepatocellular carcinoma in a western population.
    Monroe EJ; Kogut MJ; Ingraham CR; Kwan SW; Hippe DS; Padia SA
    Clin Radiol; 2015 Jul; 70(7):730-5. PubMed ID: 25921616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.
    Fahmueller YN; Nagel D; Hoffmann RT; Tatsch K; Jakobs T; Stieber P; Holdenrieder S
    Int J Cancer; 2013 May; 132(10):2349-58. PubMed ID: 23047645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.